Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy-Reference-Cited by-同舟云学术

Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy

Published:2022-06-02 Issue:11 Volume:82 Page:1098-1106
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Cho Hae Lin¹,Murthy Vedang²^ORCID,Mouw Kent W.³^ORCID,D'Amico Anthony V.³^ORCID,Nguyen Paul L.³^ORCID,Leeman Jonathan E.³^ORCID,Dee Edward Christopher⁴^ORCID

Affiliation:

1. Harvard Medical School Boston Massachusetts USA

2. Department of Radiation Oncology Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI) Mumbai India

3. Department of Radiation Oncology Brigham and Women's Hospital and Dana Farber Cancer Institute Boston Massachusetts USA

4. Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York USA

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24362

Reference24 articles.

1. Elective Nodal Radiotherapy for Prostate Cancer: For None, Some, or all?

2. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial

3. Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiotherapy: The NRG Oncology/RTOG 0534 SPPORT Trial

4. Radiation Therapy Oncology Group. Androgen deprivation therapy and high dose radiotherapy with or without whole‐pelvic radiotherapy in unfavorable intermediate or favorable high risk prostate cancer: a phase III randomized trial [Internet].clinicaltrials.gov;2019Jun [cited 2021 Oct 28]. Report No.: NCT01368588.https://clinicaltrials.gov/ct2/show/NCT01368588

5. Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk of second malignancies following prostate cancer radiotherapy in the era of conformal radiotherapy: a statement of the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO);Strahlentherapie und Onkologie;2024-08-28

2. La radiothérapie du cancer de la prostate augmente-t-elle le risque de seconds cancers ?;Cancer/Radiothérapie;2024-06

3. Second Malignancy Probabilities in Patients With Breast Cancer Treated With Conventional Versus Hypofractionated External Beam Radiation Therapy in the Adjuvant Setting;Clinical Oncology;2023-12

4. An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers;Technology in Cancer Research & Treatment;2023-01

5. Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study;Technology in Cancer Research & Treatment;2023-01